Oxford Biomedica (OXB) Share Price

Health Care Sector


NOTE: This is based on 126 open tips for Oxford Biomedica (OXB)


Oxford Biomedica (OXB)
Latest Quote Price

190.00p

Oxford Biomedica (OXB)
Price Change (%)

0.00%


Latest Bid : 187.20p Latest Ask : 193.80p
High Today : 190.00p Low Today : 189.91p
This Years High : 470.00p This Years Low : 166.80p
Volume : 10,531 MKT Cap : £191.86M
Trading Velocity : Premium Only Activity Score : Premium Only
Consensus Score : Premium Only Momentum Score : Premium Only

Stock Splits and Consolidations

30/05/2018 – Stock Consolidation 50.000:1.000


Oxford Biomedica (OXB) Overview

Oxford Biomedica develops innovative new IP-protected , LentiVector® based therapies, leveraging our internal research expertise and know-how. We select patient-centric product candidates and progress these through proof-of-concept, and into early clinical development, before either seeking third-party funding for full development and commercialisation or to develop further in-house.

Oxford Biomedica (OXB) Latest Tips

Type Tipster SectorScore Start date Performance
Hold Dominic Walsh Premium Only 2024-03-12 00:05:00 12/03/2024 -12.52%
Outperform RBC Capital Premium Only 2024-03-05 07:28:00 05/03/2024 11.16%
Neutral JP Morgan Premium Only 2023-12-05 05:04:00 05/12/2023
Outperform RBC Capital Premium Only 2023-10-18 05:49:00 18/10/2023 -30.92%
Hold Liberum Capital Premium Only 2023-09-26 16:30:00 26/09/2023 4.55%

You are missing Premium Content from this chart

Please Log In to a premium account or Sign Up today to view premium content.


Oxford Biomedica (OXB) Active Short Positions

Fund Manager Position Date
Millennium International Management LP 0.61% 14/03/2024

See more short positions...


Latest Bid : 187.20p Latest Ask : 193.80p
High Today : 190.00p Low Today : 189.91p
This Years High : 470.00p This Years Low : 166.80p
Volume : 10,531 MKT Cap : £191.86M

Oxford Biomedica Overview

Oxford Biomedica develops innovative new IP-protected , LentiVector® based therapies, leveraging our internal research expertise and know-how. We select patient-centric product candidates and progress these through proof-of-concept, and into early clinical development, before either seeking third-party funding for full development and commercialisation or to develop further in-house.

NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.


Latest Oxford Biomedica Tips

Type Tipster SectorScore Start date Performance
Hold Dominic Walsh Premium Only 2024-03-12 00:05:00 12/03/2024 -12.52%
Outperform RBC Capital Premium Only 2024-03-05 07:28:00 05/03/2024 11.16%
Neutral JP Morgan Premium Only 2023-12-05 05:04:00 05/12/2023
Outperform RBC Capital Premium Only 2023-10-18 05:49:00 18/10/2023 -30.92%
Hold Liberum Capital Premium Only 2023-09-26 16:30:00 26/09/2023 4.55%

Stock Splits and Consolidations

30/05/2018 – Stock Consolidation 50.000:1.000